Rep. Waxman Launches Salvo Against FDA Pre-emption Of State Tort Suits
Executive Summary
Congressman Henry Waxman lined up prominent physicians, a former FDA commissioner and a famous actor to make a case against pre-emption
You may also be interested in...
Who’s Next In Congressional Hot Seat? Pharma Industry Could Replace FDA
Congress will not keep up its intense scrutiny of FDA when President-elect Barack Obama takes office, drug and device lawyers predict. Instead, Capitol Hill will shift its attention to pharmaceutical company practices
Who’s Next In Congressional Hot Seat? Pharma Industry Could Replace FDA
Congress will not keep up its intense scrutiny of FDA when President-elect Barack Obama takes office, drug and device lawyers predict. Instead, Capitol Hill will shift its attention to pharmaceutical company practices
Drug Industry Braces For Supreme Court Ruling In Wyeth Pre-emption Case
This week everyone's attention is riveted on the presidential election. But for the pharmaceutical industry there is another issue just as compelling. On Nov. 3, the U.S. Supreme Court will hear oral arguments in the case that will decide the future of product liability litigation